Akumin (TSX:AKU) Other Stockholders Equity: C$0.0 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:AKU Akumin Inc TSX:AKU
10 GF Score
Price C$0.53
View Full Analysis

What is Akumin Other Stockholders Equity?

Akumin TSX:AKU 10 Other Stockholders Equity is C$0.0 Mil as of Sep. 2023. GuruFocus rates TSX:AKU with a GF Score™ of 10/100.

Akumin's Other Stockholders Equity for the quarter that ended in Sep. 2023 was C$0.0 Mil.

Akumin's quarterly Other Stockholders Equity increased from Mar. 2023 (C$0.0 Mil) to Jun. 2023 (C$0.0 Mil) but then declined from Jun. 2023 (C$0.0 Mil) to Sep. 2023 (C$0.0 Mil).

Akumin's annual Other Stockholders Equity increased from Dec. 2020 (C$-0.0 Mil) to Dec. 2021 (C$0.0 Mil) but then declined from Dec. 2021 (C$0.0 Mil) to Dec. 2022 (C$-0.0 Mil).

Akumin Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Akumin's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akumin Other Stockholders Equity Chart

Akumin Annual Data
Trend Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
Get a 7-Day Free Trial 2.34 0.00 -0.00 0.00 -0.00

Akumin Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
TSX:AKU
10GF Score
Akumin Inc TSX:AKU
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akumin Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of C$0.0 Mil mean?
Akumin (TSX:AKU) has a Other Stockholders Equity of C$0.0 Mil as of Sep. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Akumin and its competitors.
Is Akumin's Other Stockholders Equity too high?
Akumin's current Other Stockholders Equity is C$0.0 Mil. Overall, Akumin has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Akumin's Other Stockholders Equity compare to LMDX and CNTG?
Akumin's Other Stockholders Equity of C$0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Akumin and its competitors. Akumin's current Other Stockholders Equity is C$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akumin stock overvalued right now?
Akumin (TSX:AKU) has a current Other Stockholders Equity of C$0.0 Mil. The current Other Stockholders Equity is C$0.0 Mil. Akumin's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Akumin (TSX:AKU), the current Other Stockholders Equity is C$0.0 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Akumin Business Description

Address 8300 West Sunrise Boulevard, Plantation, FL, USA, 33322
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
10GF Score

Get the complete analysis for TSX:AKU

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.53
Price